Cite
HARVARD Citation
Flueckiger, S. et al. (n.d.). Inhibition of oncogenic MAPK signaling in melanoma triggers SOX2-dependent adaptive drug resistance programs. European journal of cancer. pp. S206-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Flueckiger, S. et al. (n.d.). Inhibition of oncogenic MAPK signaling in melanoma triggers SOX2-dependent adaptive drug resistance programs. European journal of cancer. pp. S206-. [Online].